Annette Regan

(she/her/hers)

9

Articles

0

Comments

Annette Regan is an epidemiologist with a special interest in vaccines, maternal health, and pregnancy. She completed an MPH in epidemiology at the Rollins School of Public Health, Emory University in 2006, and a PhD in infectious diseases at the University of Western Australia in 2016. Her PhD work focused on the uptake, safety and effectiveness of influenza vaccination during pregnancy in Western Australia and included a large data linkage component, and she has continued interest in the application of linked data for maternal and child health epidemiology, burden of disease, public health surveillance, and cohort studies.

She has previously worked as an epidemiologist for state and federal public health agencies, including the US Centers for Disease Control and Prevention (CDC). During her time at CDC, she coordinated national surveillance activities and had the opportunity to serve in emergency response operations, including the response to the 2009 influenza A/H1N1 pandemic. After leaving CDC in 2011, she spent seven years living in Australia working for the state health department in Western Australia. During her time there, she implemented several communicable disease prevention and surveillance programs, including the development of novel surveillance tools for monitoring emerging infectious disease threats such as Ebola virus.

Since returning to the US in 2018, she has been tenure-track and tenured faculty at the Texas A&M University School of Public Health and the University of San Francisco, where she lectured on epidemiologic methods, infectious disease epidemiology, and reproductive health. Over the course of her career, she has mentored and supervised undergraduate, master’s, and doctoral students as well as postdoctoral research fellows. She joined the Fielding School of Public Health (UCLA) in 2019 as Adjunct faculty.

In addition to her public health and teaching experience, Dr. Regan has an active research portfolio in maternal health and immunization and continues to collaborate internationally with researchers in Australia, Norway, Canada, and across the US. She has published >130 peer-reviewed papers in public health and medical journals, including the Lancet, Lancet Global Health, Lancet Infectious Diseases, American Journal of Epidemiology, and the American Journal of Public Health. Her research has contributed to policy briefs and improvements in public health programs related to maternal and child health.

Experience

  • 2019–present
    Adjunct Assistant Professor, UCLA
  • 2024–present
    Research Scientist II, Kaiser Permanente Southern California
  • 2023–2024
    Associate Professor (tenured), University of San Francisco
  • 2020–2023
    Assistant Professor, University of San Francisco
  • 2018–2020
    Assistant Professor, Texas A&M University
  • 2018–2019
    NHMRC Early Career Research Fellow, Curtin University
  • 2016–2018
    Research Fellow, Curtin University
  • 2012–2016
    PhD Candidate, University of Western Australia
  • 2013–2016
    Vaccine Epidemiologist, Western Australia Department of Health
  • 2007–2011
    Epidemiologist, US Centers for Disease Control and Prevention
  • 2006–2007
    Health Care Analyst II, Northrop Grumman (CTR to CDC)

Education

  • 2016 
    School of Pathology and Laboratory Medicine, University of Western Australia, PhD, Infectious Diseases
  • 2016 
    School of Pathology and Laboratory Medicine, University of Western Australia, Masters of Infectious Diseases
  • 2006 
    Rollins School of Public Health, Emory University, Masters in Public Health, Epidemiology
  • 2004 
    University of Florida, Bachelors of Science, Psychology

Grants and Contracts

  • 2022
    Evaluating teen-parent dynamics in adolescent COVID-19 vaccine acceptance and uptake
    Role:
    PI
    Funding Source:
    National Institute of Child Health and Human Development
  • 2022
    Support for analysis of global influenza and COVID-19 vaccine effectiveness evaluation
    Role:
    IPA Recipient
    Funding Source:
    Centers for Disease Control and Prevention
  • 2022
    Uptake, safety and effectiveness of COVID-19 vaccines during pregnancy
    Role:
    PI
    Funding Source:
    National Institute of Allergy and Infectious Diseases
  • 2019
    Support for analysis of influenza vaccine clinical trial in healthcare personnel
    Role:
    IPA Recipient
    Funding Source:
    Centers for Disease Control and Prevention
  • 2019
    Predictors and barriers to achieving immunization in rural and urban areas
    Role:
    PI
    Funding Source:
    Health Resources and Services Administration
  • 2018
    Informing vaccination strategies for pregnant women through linked population health data
    Role:
    PI
    Funding Source:
    National Health and Medical Research Council
  • 2018
    Links2HealthierBubs: Influenza and pertussis vaccine effectiveness and safety in pregnancy
    Role:
    PI
    Funding Source:
    National Health and Medical Research Council
  • 2016
    Multi-country investigation of influenza vaccine effectiveness in preventing hospitalization and other adverse outcomes associated with influenza among pregnant women
    Role:
    Subawardee
    Funding Source:
    Centers for Disease Control and Prevention

Professional Memberships

  • Society for Epidemiologic Research
  • Society for Pediatric and Perinatal Epidemiologic Research
  • American Public Health Association
  • Infectious Disease Society of America

Contact Annette for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision